Primary neuroblastoma uptake of /sub 99m/technetium methylene diphosphonate

Conference · Sat Nov 01 04:00:00 EST 1980 · Radiology; (United States)

OSTI ID:7056390

Smith, F W; Gilday, D L; Ash, J M; Reid, R H

Forty patients, ages three days to 12 years, with neuroblastomas had bone scans with /sub 99m/technetium methylene diphosphonate (/sub 99m/Tc-MDP) as part of their pretreatment examination. Twenty-four (60%) had primary tumor uptake and 16 (40%) did not. No difference was seen between the two groups in the incidence of tumor calcification or necrosis. No relationship between the level of urinary vanillylmandelic acid (VMA) and the presence of primary tumor uptake of /sub 99m/Tc-MDP was found. The possible causes for the localization of /sub 99m/Tc-MDP are discussed.

• Research Organization: Hospital for Sick Children, Toronto, Ontario
• OSTI ID: 7056390
• Conference Information: Journal Name: Radiology; (United States) Journal Volume: 137:2
• Country of Publication: United States
• Language: English

Related Subjects

550601 -- Medicine-- Unsealed Radionuclides in Diagnostics
560171* -- Radiation Effects-- Nuclide Kinetics & Toxicology-- Man-- (-1987)
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
AGE GROUPS
ANIMALS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
CALCINOSIS
CHILDREN
COUNTING TECHNIQUES
DISEASES
HOURS LIVING RADIOISOTOPES
INTERMEDIATE MASS NUCLEI
ISOMERIC NUCLEI
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
MAMMALS
MAN
NECROSIS
NEOPLASMS
NUCLEI
ODD-EVEN NUCLEI
ORGANS
PATHOLOGICAL CHANGES
PRIMATES
RADIOISOTOPE SCANNING
RADIOISOTOPES
RADIONUCLIDE KINETICS
SKELETON
TECHNETIUM 99
TECHNETIUM ISOTOPES
UPTAKE
VERTEBRATES
YEARS LIVING RADIOISOTOPES